{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:51:50Z","timestamp":1792842710020,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373174"],"award-info":[{"award-number":["82373174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373175"],"award-info":[{"award-number":["82373175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04700-y","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:43:16Z","timestamp":1781703796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrin \u03b16-targeted photodynamic therapy potentiates PD-1 blockade in MSS colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Ting","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Kun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Na","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Li","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Kai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"3","key":"4700_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4700_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","volume":"43","author":"R Abedizadeh","year":"2023","unstructured":"Abedizadeh R, Majidi F, Khorasani HR, Abedi H, Sabour D. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer Metastasis Rev. 2023;43(2):729\u201353.","journal-title":"Cancer Metastasis Rev"},{"issue":"41","key":"4700_CR3","doi-asserted-by":"publisher","first-page":"15049","DOI":"10.3748\/wjg.v20.i41.15049","volume":"20","author":"C De Divitiis","year":"2014","unstructured":"De Divitiis C, Nasti G, Montano M, Fisichella R, Iaffaioli RV, Berretta M. Prognostic and predictive response factors in colorectal cancer patients: between hope and reality. World J Gastroenterol. 2014;20(41):15049\u201359.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"4700_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/cac2.12095","volume":"40","author":"F Wang","year":"2020","unstructured":"Wang F, Wang Z-X, Chen G, Luo H-Y, Zhang D-S, Qiu M-Z, Wang D-S, Pan Z-Z, Shen L, Li J, et al. Expert opinions on immunotherapy for patients with colorectal cancer. Cancer Commun (Lond). 2020;40(10):467\u201372.","journal-title":"Cancer Commun (Lond)"},{"issue":"9","key":"4700_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/cac2.12199","volume":"41","author":"C Zhou","year":"2021","unstructured":"Zhou C, Jiang T, Li R, Yuan Y, Xie W, Huang X, Wang Q, Chang H, Chen G, Li Y, et al. Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real-world retrospective analysis. Cancer Commun (Lond). 2021;41(9):921\u20134.","journal-title":"Cancer Commun (Lond)"},{"key":"4700_CR6","doi-asserted-by":"crossref","unstructured":"Takei S, Tanaka Y, Lin Y-T, Koyama S, Fukuoka S, Hara H, Nakamura Y, Kuboki Y, Kotani D, Kojima T et al. Multiomic molecular characterization of the response to combination immunotherapy in MSS\/pMMR metastatic colorectal cancer. J Immunother Cancer 2024, 12(2):e008210.","DOI":"10.1136\/jitc-2023-008210"},{"issue":"4","key":"4700_CR7","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1021\/cr5004198","volume":"115","author":"SS Lucky","year":"2015","unstructured":"Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem Rev. 2015;115(4):1990\u20132042.","journal-title":"Chem Rev"},{"issue":"11","key":"4700_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","volume":"17","author":"X Li","year":"2020","unstructured":"Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;17(11):657\u201374.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"4700_CR9","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1021\/acs.chemrev.8b00554","volume":"119","author":"P Di Mascio","year":"2019","unstructured":"Di Mascio P, Martinez GR, Miyamoto S, Ronsein GE, Medeiros MHG, Cadet J. Singlet Molecular Oxygen Reactions with Nucleic Acids, Lipids, and Proteins. Chem Rev. 2019;119(3):2043\u201386.","journal-title":"Chem Rev"},{"issue":"4","key":"4700_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1572-1000(05)00007-4","volume":"1","author":"AP Castano","year":"2004","unstructured":"Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther. 2004;1(4):279\u201393.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"4","key":"4700_CR11","first-page":"250","volume":"61","author":"P Agostinis","year":"2011","unstructured":"Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250\u201381.","journal-title":"CA Cancer J Clin"},{"key":"4700_CR12","doi-asserted-by":"crossref","unstructured":"Zhou Y, Zhang W, Wang B, Wang P, Li D, Cao T, Zhang D, Han H, Bai M, Wang X et al. Mitochondria-targeted photodynamic therapy triggers GSDME-mediated pyroptosis and sensitizes anti-PD-1 therapy in colorectal cancer. J Immunother Cancer 2024, 12(3):e008054.","DOI":"10.1136\/jitc-2023-008054"},{"issue":"16","key":"4700_CR13","doi-asserted-by":"publisher","first-page":"9093","DOI":"10.1002\/anie.202016399","volume":"60","author":"M Wu","year":"2021","unstructured":"Wu M, Liu X, Chen H, Duan Y, Liu J, Pan Y, Liu B. Activation of Pyroptosis by Membrane-Anchoring AIE Photosensitizer Design: New Prospect for Photodynamic Cancer Cell Ablation. Angew Chem Int Ed Engl. 2021;60(16):9093\u20138.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"11","key":"4700_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","volume":"11","author":"J Fucikova","year":"2020","unstructured":"Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 2020;11(11):1013.","journal-title":"Cell Death Dis"},{"issue":"22","key":"4700_CR15","doi-asserted-by":"publisher","first-page":"e2201734","DOI":"10.1002\/advs.202201734","volume":"9","author":"Z Li","year":"2022","unstructured":"Li Z, Lai X, Fu S, Ren L, Cai H, Zhang H, Gu Z, Ma X, Luo K. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency. Adv Sci (Weinh). 2022;9(22):e2201734.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"4700_CR16","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1039\/D0CS00173B","volume":"50","author":"X Zhao","year":"2021","unstructured":"Zhao X, Liu J, Fan J, Chao H, Peng X. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application. Chem Soc Rev. 2021;50(6):4185\u2013219.","journal-title":"Chem Soc Rev"},{"issue":"5","key":"4700_CR17","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/cplu.202000203","volume":"85","author":"M Liu","year":"2020","unstructured":"Liu M, Li C. Recent Advances in Activatable Organic Photosensitizers for Specific Photodynamic Therapy. ChemPlusChem. 2020;85(5):948\u201357.","journal-title":"ChemPlusChem"},{"key":"4700_CR18","doi-asserted-by":"crossref","unstructured":"Liu Y, Xu S, Lyu Q, Huang Y, Wang W. Ce6 nanoassemblies: Molecular mechanism and strategies for combinational anticancer therapy. Aggregate 2023, 5(1):443.","DOI":"10.1002\/agt2.443"},{"issue":"2","key":"4700_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1021\/acsabm.2c00891","volume":"6","author":"A Hak","year":"2023","unstructured":"Hak A, Ali MS, Sankaranarayanan SA, Shinde VR, Rengan AK. Chlorin e6: A Promising Photosensitizer in Photo-Based Cancer Nanomedicine. ACS Appl Bio Mater. 2023;6(2):349\u201364.","journal-title":"ACS Appl Bio Mater"},{"issue":"2","key":"4700_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00259-022-06031-0","volume":"50","author":"X Li","year":"2023","unstructured":"Li X, Hsu JC, Son MH, Ha LN, Cai W. Cancer photodynamic therapy with chlorin e6-loaded, goat milk-derived extracellular vesicles: [(18)F]FDG lights up the way. Eur J Nucl Med Mol Imaging. 2023;50(2):247\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4700_CR21","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.pdpdt.2020.102091","volume":"34","author":"IS Mfouo-Tynga","year":"2021","unstructured":"Mfouo-Tynga IS, Dias LD, Inada NM, Kurachi C. Features of third generation photosensitizers used in anticancer photodynamic therapy: Review. Photodiagnosis Photodyn Ther. 2021;34:102091.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"4700_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-4419-6066-5_5","volume":"674","author":"S Cabodi","year":"2010","unstructured":"Cabodi S, Di Stefano P, Leal MPC, Tinnirello A, Bisaro B, Morello V, Damiano L, Aramu S, Repetto D, Tornillo G, et al. Integrins and signal transduction. Adv Exp Med Biol. 2010;674:43\u201354.","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"4700_CR23","doi-asserted-by":"publisher","first-page":"14684","DOI":"10.18632\/oncotarget.7407","volume":"7","author":"J-F Beaulieu","year":"2016","unstructured":"Beaulieu J-F, Herring E, Kanaoka S, Tremblay \u00c9. Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages. Oncotarget. 2016;7(12):14684\u201392.","journal-title":"Oncotarget"},{"issue":"4","key":"4700_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","volume":"25","author":"L Seguin","year":"2015","unstructured":"Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25(4):234\u201340.","journal-title":"Trends Cell Biol"},{"key":"4700_CR25","doi-asserted-by":"crossref","unstructured":"Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002, 2(2):91\u2013100.","DOI":"10.1038\/nrc727"},{"issue":"1","key":"4700_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41392-020-00266-9","volume":"5","author":"S Gao","year":"2020","unstructured":"Gao S, Jia B, Feng G, Dong C, Du H, Bai L, Zhong Q, Ma Q, Zeng M, Wang F. First-in-human pilot study of an integrin \u03b16-targeted radiotracer for SPECT imaging of breast cancer. Signal Transduct Target Ther. 2020;5(1):147.","journal-title":"Signal Transduct Target Ther"},{"key":"4700_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2019.08.003","volume":"310","author":"G-K Feng","year":"2019","unstructured":"Feng G-K, Ye J-C, Zhang W-G, Mei Y, Zhou C, Xiao Y-T, Li X-L, Fan W, Wang F, Zeng M-S. Integrin \u03b16 targeted positron emission tomography imaging of hepatocellular carcinoma in mouse models. J Control Release. 2019;310:11\u201321.","journal-title":"J Control Release"},{"issue":"1","key":"4700_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/msp2.18","volume":"1","author":"XL Li","year":"2023","unstructured":"Li XL, Shen ZL, Wang QL, Ye JC, Zhang WB, Li YH, Feng GK, Zeng MS. Integrin \u03b16: a potential target for cancer molecular imaging and targeting therapy. Malignancy Spectr. 2023;1(1):30\u201345.","journal-title":"Malignancy Spectr"},{"issue":"13","key":"4700_CR29","doi-asserted-by":"publisher","first-page":"15560","DOI":"10.1021\/acsomega.9b01920","volume":"4","author":"Y-T Xiao","year":"2019","unstructured":"Xiao Y-T, Zhou C, Ye J-C, Yang X-C, Li Z-J, Zheng X-B, Mei Y, Li X-L, Zhang W-G, Fan W, et al. Integrin \u03b16-Targeted Positron Emission Tomography Imaging of Colorectal Cancer. ACS Omega. 2019;4(13):15560\u20136.","journal-title":"ACS Omega"},{"key":"4700_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.eng.2023.11.012","volume":"35","author":"J-C Ye","year":"2024","unstructured":"Ye J-C, Li W-Q, Chen M-L, Shi Q-K, Wang H, Li X-L, Li Y-H, Yang J, Wang Q-L, Hu F, et al. Targeted Therapy of Central Nervous System Acute Lymphoblastic Leukemia with an Integrin \u03b16-Targeted Self-Assembling Proapoptotic Nanopeptide. Engineering. 2024;35:226\u201340.","journal-title":"Engineering"},{"issue":"6","key":"4700_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"4700_CR32","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1093\/oncolo\/oyae013","volume":"29","author":"DC Guven","year":"2024","unstructured":"Guven DC, Kavgaci G, Erul E, Syed MP, Magge T, Saeed A, Yalcin S, Sahin IH. The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review. Oncologist. 2024;29(5):e580\u2013600.","journal-title":"Oncologist"},{"key":"4700_CR33","doi-asserted-by":"crossref","unstructured":"Rodrigues JA, Correia JH. Photodynamic Therapy for Colorectal Cancer: An Update and a Look to the Future. Int J Mol Sci 2023, 24(15):12204.","DOI":"10.3390\/ijms241512204"},{"key":"4700_CR34","doi-asserted-by":"publisher","first-page":"1050421","DOI":"10.3389\/fimmu.2022.1050421","volume":"13","author":"B Gu","year":"2022","unstructured":"Gu B, Wang B, Li X, Feng Z, Ma C, Gao L, Yu Y, Zhang J, Zheng P, Wang Y, et al. Photodynamic therapy improves the clinical efficacy of advanced colorectal cancer and recruits immune cells into the tumor immune microenvironment. Front Immunol. 2022;13:1050421.","journal-title":"Front Immunol"},{"issue":"1","key":"4700_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7150\/thno.67300","volume":"12","author":"B Ji","year":"2022","unstructured":"Ji B, Wei M, Yang B. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy. Theranostics. 2022;12(1):434\u201358.","journal-title":"Theranostics"},{"issue":"5","key":"4700_CR36","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, Chan WCW. Analysis of nanoparticle delivery to tumours. Nat Reviews Mater. 2016;1(5):16014.","journal-title":"Nat Reviews Mater"},{"issue":"1","key":"4700_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41392-025-02140-y","volume":"10","author":"Y Cai","year":"2025","unstructured":"Cai Y, Chai T, Nguyen W, Liu J, Xiao E, Ran X, Ran Y, Du D, Chen W, Chen X. Phototherapy in cancer treatment: strategies and challenges. Signal Transduct Target Ther. 2025;10(1):115.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"4700_CR38","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/adma.201502454","volume":"28","author":"Q Zou","year":"2015","unstructured":"Zou Q, Liu K, Abbas M, Yan X. Peptide-Modulated Self-Assembly of Chromophores toward Biomimetic Light-Harvesting Nanoarchitectonics. Adv Mater. 2015;28(6):1031\u201343.","journal-title":"Adv Mater"},{"key":"4700_CR39","doi-asserted-by":"publisher","first-page":"33376","DOI":"10.1038\/srep33376","volume":"6","author":"T Hu","year":"2016","unstructured":"Hu T, Zhou R, Zhao Y, Wu G. Integrin \u03b16\/Akt\/Erk signaling is essential for human breast cancer resistance to radiotherapy. Sci Rep. 2016;6:33376.","journal-title":"Sci Rep"},{"issue":"9","key":"4700_CR40","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.apsb.2021.01.004","volume":"11","author":"M Li","year":"2021","unstructured":"Li M, Wang Y, Li M, Wu X, Setrerrahmane S, Xu H. Integrins as attractive targets for cancer therapeutics. Acta Pharm Sinica B. 2021;11(9):2726\u201337.","journal-title":"Acta Pharm Sinica B"},{"key":"4700_CR41","doi-asserted-by":"crossref","unstructured":"Li X, Xie K, Wang Q, Ye J, Zhang W, Yang J, Zeng M, Feng G. Integrin \u03b16 Targeted Tumor Theranostics. Phenomics 2026.","DOI":"10.1007\/s43657-024-00194-6"},{"issue":"4","key":"4700_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2478\/jtim-2021-0046","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Hou K, Jin Y, Bao B, Tang S, Qi J, Yang Y, Che X, Liu Y, Hu X, et al. Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways. J translational Intern Med. 2021;9(4):249\u201363.","journal-title":"J translational Intern Med"},{"issue":"1","key":"4700_CR43","first-page":"143","volume":"19","author":"L Zhao","year":"2019","unstructured":"Zhao L, Chi W, Cao H, Cui W, Meng W, Guo W, Wang B. Screening and clinical significance of tumor markers in head and neck squamous cell carcinoma through bioinformatics analysis. Mol Med Rep. 2019;19(1):143\u201354.","journal-title":"Mol Med Rep"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04700-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04700-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04700-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T02:48:24Z","timestamp":1787712504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04700-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4700"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04700-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Sun Yat-sen University Cancer Center (L025501202401002). Approval for the use of human samples was obtained from the Ethics Review Committee of the Sun Yat-sen University Cancer Center with waiver of informed consents (B2025-670-01).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"810"}}